BHI Skin

BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR ORAL HUMAN OTC DRUG

BHI Skin is an FDA drug label for the active ingredient BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR manufactured by MediNatura Inc administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20220707.

Generic name
BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR
Manufacturer
MediNatura Inc
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
62795-1016
Application
N/A
Label effective
20220707

About this product

BHI Skin is an FDA-registered drug product whose active ingredient is BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR. It is labelled by MediNatura Inc taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 62795-1016, label effective 20220707. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

What it is used for

Across FDA labelling, products containing BERBERIS VULGARIS ROOT BARK, GRAPHITE, HYDROFLUORIC ACID, LYCOPODIUM CLAVATUM SPORE, PETROLATUM, TOXICODENDRON PUBESCENS LEAF, SEPIA OFFICINALIS JUICE, AND SULFUR are most often described in connection with: temporary relief, minor eczema, symptoms rough, scaly skin. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Active ingredients

ACTIVE INGREDIENTS Each tablet contains: *Berberis vulgaris 6X, Graphites 10X, Hydrofluoricum acidum 10X, *Lycopodium clavatum 12X, *Petroleum 10X, *Rhus toxicodendron 8X, *Sepia 10X, *Sulphur 12X 37.5 mg each. *Natural Ingredients

Indications & Usage

USES For the temporary relief of minor eczema symptoms: rough scaly skin, itching skin, redness

Dosage & Administration

Directions At first sign of symptoms: Adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. Standard dosage: Adults and children 4 years and older: Take 1-2 tablet every 4 to 6 hours. Do not exceed 12 tablets in 24 hours. For children under 4, consult your health professional. Allow tablets to dissolve completely in the mouth, do not swallow.

Warnings

WARNINGS SECTION If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If symptoms persist or worsen, a health professional should be consulted. Do not use if known sensitivity to BHI Skin or any of its ingredients exists.

Frequently asked questions

What is BHI Skin used for?
USES For the temporary relief of minor eczema symptoms: rough scaly skin, itching skin, redness

Who makes BHI Skin?
MediNatura Inc is the labeler of record for BHI Skin.

What form does BHI Skin come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is BHI Skin prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Has BHI Skin been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.

This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.